Novozymes A/S
Novozymes A/S (NVZMY) Stock Overview
Explore Novozymes A/S’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
25.6B
P/E Ratio
13.46
EPS (TTM)
$1.45
ROE
0.13%
NVZMY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Novozymes A/S (NVZMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 31.17, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $73.68.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.46 and a market capitalization of 25.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.